Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gary R McLean

Showing results (31-40 of 40) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 40 results.
Pharmaceutics|November 27, 2025
Post-Synthesis Modulation of the Physicochemical Properties of Green-Synthesized Iron Oxide Nanoparticles with Tween 80 to Enhance Their Antibacterial Activity and BiocompatibilityMarwa R Bakkar, Alaa M Ali, Gehad E Elkhouly, et al.
Clinical and Diagnostic Laboratory Immunology|January 11, 2003
Specificity and diversity of antibodies to Mycobacterium tuberculosis arabinomannanJosephine Anne D Navoa, Suman Laal, Liise-Anne Pirofski, et al.
The Journal of Infectious Diseases|March 13, 2018
Epitope-Specific Humoral Responses to Human Cytomegalovirus Glycoprotein-B Vaccine With MF59: Anti-AD2 Levels Correlate With Protection From ViremiaIlona Baraniak, Barbara Kropff, Gary R McLean, et al.
The Journal of General Virology|June 13, 2023
A temperature-dependent virus-binding assay reveals the presence of neutralizing antibodies in human cytomegalovirus gB vaccine recipients' seraAriane C Gomes, Ilona A Baraniak, Megan R McIntosh, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 25, 2018
Protection from cytomegalovirus viremia following glycoprotein B vaccination is not dependent on neutralizing antibodiesIlona Baraniak, Barbara Kropff, Lyn Ambrose, et al.
Antiviral Research|June 30, 2012
Rhinovirus infections and immunisation induce cross-serotype reactive antibodies to VP1Gary R McLean, Ross P Walton, Shweta Shetty, et al.
Antibiotics (Basel, Switzerland)|July 2, 2021
Rhamnolipids Nano-Micelles as a Potential Hand SanitizerMarwa Reda Bakkar, Ahmed Hassan Ibrahim Faraag, Elham R S Soliman, et al.
Plos Pathogens|October 3, 2013
Cross-serotype immunity induced by immunization with a conserved rhinovirus capsid proteinNicholas Glanville, Gary R McLean, Bruno Guy, et al.
Plos Pathogens|August 13, 2013
An anti-human ICAM-1 antibody inhibits rhinovirus-induced exacerbations of lung inflammationStephanie Traub, Alexandra Nikonova, Alan Carruthers, et al.
Nature Communications|March 11, 2025
Integrated histopathology, spatial and single cell transcriptomics resolve cellular drivers of early and late alveolar damage in COVID-19Jimmy Tsz Hang Lee, Sam N Barnett, Kenny Roberts, et al.
Pageof 4

Showing results (31-40 of 40) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 40 results.
Pharmaceutics|November 27, 2025
Post-Synthesis Modulation of the Physicochemical Properties of Green-Synthesized Iron Oxide Nanoparticles with Tween 80 to Enhance Their Antibacterial Activity and BiocompatibilityMarwa R Bakkar, Alaa M Ali, Gehad E Elkhouly, et al.
Clinical and Diagnostic Laboratory Immunology|January 11, 2003
Specificity and diversity of antibodies to Mycobacterium tuberculosis arabinomannanJosephine Anne D Navoa, Suman Laal, Liise-Anne Pirofski, et al.
The Journal of Infectious Diseases|March 13, 2018
Epitope-Specific Humoral Responses to Human Cytomegalovirus Glycoprotein-B Vaccine With MF59: Anti-AD2 Levels Correlate With Protection From ViremiaIlona Baraniak, Barbara Kropff, Gary R McLean, et al.
The Journal of General Virology|June 13, 2023
A temperature-dependent virus-binding assay reveals the presence of neutralizing antibodies in human cytomegalovirus gB vaccine recipients' seraAriane C Gomes, Ilona A Baraniak, Megan R McIntosh, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 25, 2018
Protection from cytomegalovirus viremia following glycoprotein B vaccination is not dependent on neutralizing antibodiesIlona Baraniak, Barbara Kropff, Lyn Ambrose, et al.
Antiviral Research|June 30, 2012
Rhinovirus infections and immunisation induce cross-serotype reactive antibodies to VP1Gary R McLean, Ross P Walton, Shweta Shetty, et al.
Antibiotics (Basel, Switzerland)|July 2, 2021
Rhamnolipids Nano-Micelles as a Potential Hand SanitizerMarwa Reda Bakkar, Ahmed Hassan Ibrahim Faraag, Elham R S Soliman, et al.
Plos Pathogens|October 3, 2013
Cross-serotype immunity induced by immunization with a conserved rhinovirus capsid proteinNicholas Glanville, Gary R McLean, Bruno Guy, et al.
Plos Pathogens|August 13, 2013
An anti-human ICAM-1 antibody inhibits rhinovirus-induced exacerbations of lung inflammationStephanie Traub, Alexandra Nikonova, Alan Carruthers, et al.
Nature Communications|March 11, 2025
Integrated histopathology, spatial and single cell transcriptomics resolve cellular drivers of early and late alveolar damage in COVID-19Jimmy Tsz Hang Lee, Sam N Barnett, Kenny Roberts, et al.
Pageof 4